Demo Data from EDBT 2026 / reviewers in the wild / expert
Christopher Kearney
dblp:165/0806 · also Christopher Michel Kearney
· DBLP profile ↗
3ranked-venue papers
0as first author
0since 2021 · last 2018
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › protein function prediction
protein classification |
0.3 | 1 | 2018 | Protein classification using modified n-grams and skip-grams · Bioinform. 2018 |
Bioinformatics and computational biology › protein function prediction › protein classification
protein sequence classification |
0.3 | 1 | 2018 | Protein classification using modified n-grams and skip-grams · Bioinform. 2018 |
Methods — techniques the papers use, named apart from their topics
supervised machine learning · 0.3skip-gram · 0.3n-gram · 0.3
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2018 | Protein classification using modified n-grams and skip-gramsabstractMotivation: Classification by supervised machine learning greatly facilitates the annotation of protein characteristics from their primary sequence. However, the feature generation step in this process requires detailed knowledge of attributes used to classify the proteins. Lack of this knowledge risks the selection of irrelevant features, resulting in a faulty model. In this study, we introduce a supervised protein classification method with a novel means of automating the work-intensive feature generation step via a Natural Language Processing (NLP)-dependent model, using a modified combination of n-grams and skip-grams (m-NGSG). Results: A meta-comparison of cross-validation accuracy with twelve training datasets from nine different published studies demonstrates a consistent increase in accuracy of m-NGSG when compared to contemporary classification and feature generation models. We expect this model to accelerate the classification of proteins from primary sequence data and increase the accessibility of protein characteristic prediction to a broader range of scientists. Availability and implementation: m-NGSG is freely available at Bitbucket: https://bitbucket.org/sm_islam/mngsg/src. A web server is available at watson.ecs.baylor.edu/ngsg. Contact: [email protected]. Supplementary information: Supplementary data are available at Bioinformatics online. S. M. Ashiqul Islam, Benjamin J. Heil, Christopher Kearney, Erich J. Baker |
Bioinform. | 3 |
| 2017 | CSPred: A machine-learning-based compound model to identify the functional activities of biologically-stable toxinsabstractPharmaceutical industries are interested in Cysteine-stabilized peptides because they offer an array bioactive properties while being highly stable under a range of physiological conditions. However, it is widely appreciated that only a small fraction of this type of peptides have been experimentally discovered while a large number remain unidentified. However, identification of these cysteine-stabilized peptides using normal sequence alignment is challenging because of the high noise to signal ratio. Therefore, we propose a machine learning-based compound model to predict functional properties of cysteine-stabilized peptides from their primary sequence. We also offer a freely available web-server at http://watson.ecs.baylor.edu/cspred to make the model available to the scientific community. S. M. Ashiqul Islam, Christopher Kearney, Erich J. Baker |
BIBM | 2 |
| 2015 | PredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptidesabstractBACKGROUND: Numerous organisms have evolved a wide range of toxic peptides for self-defense and predation. Their effective interstitial and macro-environmental use requires energetic and structural stability. One successful group of these peptides includes a tri-disulfide domain arrangement that offers toxicity and high stability. Sequential tri-disulfide connectivity variants create highly compact disulfide folds capable of withstanding a variety of environmental stresses. Their combination of toxicity and stability make these peptides remarkably valuable for their potential as bio-insecticides, antimicrobial peptides and peptide drug candidates. However, the wide sequence variation, sources and modalities of group members impose serious limitations on our ability to rapidly identify potential members. As a result, there is a need for automated high-throughput member classification approaches that leverage their demonstrated tertiary and functional homology. RESULTS: We developed an SVM-based model to predict sequential tri-disulfide peptide (STP) toxins from peptide sequences. One optimized model, called PredSTP, predicted STPs from training set with sensitivity, specificity, precision, accuracy and a Matthews correlation coefficient of 94.86%, 94.11%, 84.31%, 94.30% and 0.86, respectively, using 200 fold cross validation. The same model outperforms existing prediction approaches in three independent out of sample testsets derived from PDB. CONCLUSION: PredSTP can accurately identify a wide range of cystine stabilized peptide toxins directly from sequences in a species-agnostic fashion. The ability to rapidly filter sequences for potential bioactive peptides can greatly compress the time between peptide identification and testing structural and functional properties for possible antimicrobial and insecticidal candidates. A web interface is freely available to predict STP toxins from http://crick.ecs.baylor.edu/. S. M. Ashiqul Islam, Tanvir Sajed, Christopher Kearney, Erich J. Baker |
BMC Bioinform. | 3 |